Chen, Junren http://orcid.org/0000-0003-3691-4931
Gale, Robert Peter
Funding for this research was provided by:
Chinese Academy of Medical Sciences (2021-I2M-1-001, 2022-I2M-2-003)
National Natural Science Foundation of China (82370212)
Ministry of Science and Technology of the People's Republic of China (84000-51200002)
Article History
Received: 8 December 2023
Revised: 12 December 2023
Accepted: 14 December 2023
First Online: 27 December 2023
Competing interests
: RPG is a consultant to Antengene Biotech LLC; Medical Director, FFF Enterprises Inc.; A speaker for Janssen Pharma and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support and Scientific Advisory Board, StemRad Ltd.